These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21464578)

  • 1. Changes of the Retina and Intrinsic Survival Signals in a Rat Model of Glaucoma following Brinzolamide and Travoprost Treatments.
    Park HY; Kim JH; Lee DE; Lee JH; Park CK
    Ophthalmic Res; 2011 Oct; 46(4):208-17. PubMed ID: 21464578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular pressure lowering, change of antiapoptotic molecule expression, and neuroretinal changes by dorzolamide 2%/timolol 0.5% combination in a chronic ocular hypertension rat model.
    Park HY; Lee NY; Kim JH; Park CK
    J Ocul Pharmacol Ther; 2008 Dec; 24(6):563-71. PubMed ID: 19049297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjunctive therapy with brinzolamide in patients on travoprost treatment].
    Babić N; Andreić V; Miljković A; Canadanović V; Barisić S
    Med Pregl; 2011; 64(5-6):310-4. PubMed ID: 21789924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of retinal intrinsic survival signal and effect of alpha2-adrenergic receptor agonist in the retina of the chronic ocular hypertension rat.
    Kim HS; Chang YI; Kim JH; Park CK
    Vis Neurosci; 2007; 24(2):127-39. PubMed ID: 17640403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.
    Feldman RM; Tanna AP; Gross RL; Chuang AZ; Baker L; Reynolds A; Prager TC;
    Ophthalmology; 2007 Jul; 114(7):1248-54. PubMed ID: 17509688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
    Katz G; Dubiner H; Samples J; Vold S; Sall K
    JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes has an additive effect on neural apoptosis in rat retina with chronically elevated intraocular pressure.
    Kanamori A; Nakamura M; Mukuno H; Maeda H; Negi A
    Curr Eye Res; 2004 Jan; 28(1):47-54. PubMed ID: 14704913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension.
    Wang X; Su J; Ding J; Han S; Ma W; Luo H; Hughes G; Meng Z; Yin Y; Wang Y; Li J
    Drug Des Devel Ther; 2016; 10():3449-3457. PubMed ID: 27799744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.
    Holló G; Kóthy P
    Curr Med Res Opin; 2008 Jun; 24(6):1755-61. PubMed ID: 18479590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection.
    Fu QL; Hu B; Wu W; Pepinsky RB; Mi S; So KF
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):975-85. PubMed ID: 18326721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of pioglitazone on retinal ischemia/reperfusion injury in rats.
    Zhang XY; Xiao YQ; Zhang Y; Ye W
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3912-21. PubMed ID: 23557740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.
    Holló G; Bozkurt B; Irkec M
    Expert Opin Pharmacother; 2009 Aug; 10(12):2015-24. PubMed ID: 19618994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akt is activated via insulin/IGF-1 receptor in rat retina with episcleral vein cauterization.
    Kanamori A; Nakamura M; Nakanishi Y; Nagai A; Mukuno H; Yamada Y; Negi A
    Brain Res; 2004 Oct; 1022(1-2):195-204. PubMed ID: 15353229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular pressure-lowering efficacy of brinzolamide when added to travoprost/timolol fixed combination as adjunctive therapy.
    Goldberg I; Crowston JG; Jasek MC; Stewart JA; Stewart WC;
    J Glaucoma; 2012 Jan; 21(1):55-9. PubMed ID: 21048504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the effects of travoprost and brinzolamide on intraocular pressure after phacoemulsification.
    Ermis SS; Ozturk F; Inan UU
    Eye (Lond); 2005 Mar; 19(3):303-7. PubMed ID: 15258611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of leukemia inhibitory factor in the rat retina following acute ocular hypertension.
    Hu Q; Huang C; Wang Y; Wu R
    Mol Med Rep; 2015 Nov; 12(5):6577-83. PubMed ID: 26352383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of early neuron degeneration and accompanying glial responses in the visual pathway in a rat model of acute intraocular hypertension.
    Zhang S; Wang H; Lu Q; Qing G; Wang N; Wang Y; Li S; Yang D; Yan F
    Brain Res; 2009 Dec; 1303():131-43. PubMed ID: 19765568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension.
    McKinnon SJ; Lehman DM; Kerrigan-Baumrind LA; Merges CA; Pease ME; Kerrigan DF; Ransom NL; Tahzib NG; Reitsamer HA; Levkovitch-Verbin H; Quigley HA; Zack DJ
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1077-87. PubMed ID: 11923249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension.
    Gugleta K
    Curr Med Res Opin; 2010 Jun; 26(6):1255-67. PubMed ID: 20350146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.